Morningstar‘s Stock Analysis 281310
There is no Morningstar’s Analysis data available.
Company Profile 281310
Bio-Synectics Inc specializes in the technology of nanoparticles. The company is engaged in the business of nanopharmaceuticals, materials, and drug delivery systems to pharmaceutical industries. It is focused on developing technologies which can be used to make nanoparticles of poorly soluble ingredients. The company's product consists of HydroCoQ10 and HydroCurcumin which will make CoQ10 and curcumin more bioavailable.
Seoul, Korea, Republic of